LIST OF PUBLICATIONS
Dae-Yeon SUH, Ph.D.
1. Cloning and characterization of chalcone synthase from the moss, Physcomitrella
patens. C. Jiang, C. K. Schommer, S. Y. Kim, D.-Y. Suh (2006) Phytochemistry 67,
2531-2540.
2. Crystal structure of stilbene synthase from Arachis hypogaea. Y. Shomura, I.
Torayama, D.-Y. Suh, T. Xiang, A. Kita, U. Sankawa, and K. Miki. (2005) Proteins
60, 803-806.
3. Antigenic prenylated peptide conjugates and polyclonal antibodies to detect protein
prenylation. X.-h. Liu, D.-Y. Suh, J. Call, and G. D. Prestwich. (2004) Bioconjugate
Chem. 15, 270-277.
4. Oxidosqualene Cyclase Inhibitors as Antimicrobial Agents. J.C. Hinshaw, D.-Y. Suh,
P. Garnier, F.S. Buckner, R.T. Eastman, S.P.T. Matsuda, B.M. Joubert, I. Coppens,
K.A. Joiner, S. Merali, T.E. Nash, and G.D. Prestwich. (2003) J. Med. Chem. 46,
4240-4243.
5. Chemistry and biochemistry of ginseng components: Ginsenosides and antioxidants.
B.H. Han, Y. N. Han, M. H. Park, E. S. Lee and D.-Y. Suh. (2001) Emerging Drugs
(Westbury, NY, U. S.), 1(Molecular Aspects of Asian Medicines), 387-398.
6. Bifunctional activities of valerophenone synthase in hop (Humulus lupulus L.). Y.
Okada, Y. Yamazaki, D.-Y. Suh, U. Sankawa and K. Ito. (2001) J. Am. Soc. Brew.
Chem. 59, 163-166.
7. Diverse chalcone synthase superfamily enzymes from the most primitive vascular
plant, Psilotum nudum. Y. Yamazaki, D.-Y. Suh, W. Sitthithaworn, K. Ishiguro, Y.
Kobayashi, M. Shibuya, Y. Ebizuka and U. Sankawa. (2001) Planta 214, 75-84.
8. Geranylgeranyl Diphosphate Synthase from Scoparia dulcis. Plastid Localization and
Conversion to a Farnesyl Diphosphate Synthase by Mutagenesis. W. Sitthithaworn, N.
Kojima, E. Viroonchatapan, D.-Y. Suh, N. Iwanami, T. Hayashi, M. Noji, K. Saito, Y.
Niwa, and U. Sankawa. (2001) Chem. Pharm. Bull. 49, 197-202.
9. Evidence for catalytic cystein-histidine dyad in chalcone synthase. D.-Y. Suh, K.
Fukuma, J. Kagami and U. Sankawa. (2000) Biochem. Biophys. Res. Commun. 275,
725-730.
10. Identification of amino acid residues important in the cyclization reactions of
chalcone and stilbene synthases. D.-Y. Suh, K. Fukuma, J. Kagami, Y. Yamazaki, M.
Shibuya, Y. Ebizuka and U. Sankawa. (2000) Biochem. J. 350, 229-235.
11. Geranylgeranyl diphosphate synthases from Scoparia dulcis and Croton sublyratus.
cDNA cloning, functional expression, and conversion to a farnesyl diphosphate
synthase. N. Kojima, W. Sitthithaworn, E. Viroonchatapan, D.-Y. Suh, N. Iwanami, T.
Hayashi and U. Sankawa. (2000) Chem. Pharm. Bull. 47, 1101-1103.
12. Chalcone and stilbene synthases expressed in eucaryotes exhibit reduced crossreactivity in vitro. D.-Y. Suh, J. Kagami, K. Fukuma, N. Iwanami, Y. Yamazaki, H.
Yurimoto, Y. Sakai, N. Kato, M. Shibuya, Y. Ebizuka and U. Sankawa. (2000) Chem.
Pharm. Bull. 47, 1051-1054.
13. Cross-reaction of chalcone synthase and stilbene synthase overexpressed in
Escherichia coli. T. Yamaguchi, F. Kurosaki, D.-Y. Suh, U. Sankawa, M. Nishioka,
T. Akiyama, M. Shibuya and Y. Ebizuka. (1999) FEBS Lett. 260, 457-461.
14. Different inhibitory effects of 5-S-glutathionyl- L-alanyl-L-dopa (5-S-GA-L-D)
analogues on autophosphorylation and substrate phosphorylation of Src protein
tyrosine kinase. Z.-B. Zheng, S. Nagai, N. Iwanami, D.-Y. Suh, A. Kobayashi, M.
Hijikata, S. Natori and U. Sankawa. (1999) Chem. Pharm. Bull. 47, 136-137.
15. In vitro platelet activating factor receptor inhibitory activity of pinusolide derivatives.
A structure-activity study. B.H. Han, H.O. Yang, Y.-H. Kang, D.-Y. Suh, Y.C. Kim,
H.J. Go, W.-J. Song and M.K. Park. (1998) J. Med. Chem. 41, 2626-2630.
16. Oxidation of pinusolide, via an iodohydrin intermediate, to 17-hydroxy-8,13labdadien-16,15-olid-19-oic acid methyl ester by treatment with iodic acid or periodic
acid in aqueous acetone. W.-J. Song, D.-Y. Suh, Y.-H. Kang, K. No and B.H. Han.
(1998) Bull. Kor. Chem. Soc. 19, 593-595.
17. Salicylate levels in rat stomach tissues after administration of aspalatone and
acetylsalicylic acid in relation to their ulcerogenicity. D.-Y. Suh, Y.-H. Kang and
B.H. Han. (1997) Arzneim. Forsch./Drug Res. 47(II), 126-129.
18. Metabolic cleavage of frangufoline in rodents: In vitro and in vivo study. D.-Y. Suh,
Y.C. Kim, Y.-H. Kang, Y.N. Han and B.H. Han. (1997) J. Nat. Prod. 60, 265-269.
19. Bioassay-directed studies on natural products in Korea. B.H. Han and D.-Y. Suh.
(1996) In: Natural Products Research in Korea. Seoul National University Press, pp.
97-181.
20. Inhibitory effects of Malaysian medicinal palnts on the platelet-activating factor
receptor binding. I.B. Jantan, Y.-H. Kang, D.-Y. Suh and B.H. Han. (1996) Nat.
Prod. Sci. 2, 86-89.
21. Unusual enamide cleavage of frangufoline under mild acidic condition. D.-Y. Suh,
Y.C. Kim, Y.N. Han and B.H. Han. (1996) Heterocycles 43, 2347-2351.
22. Studies on platelet activating factor antagonists from Korean medicinal plants. B.H.
Han, H.O. Yang, Y.H. Kang, Y.C. Kim, H.J. Go and D.-Y. Suh. (1996) Korean J.
Med. Chem. 6, 128-134.
23. In vitro effect of aspalatone on platelet aggregation and thromboxane production in
human platelet rich plasma. D.-Y. Suh and B.H. Han. (1996) J. Appl. Pharm. 4, 122126.
24. Absolute configuration of a cyclopeptide alkaloid, sanjoinine-G1, from Zizyphus
vulgaris var. spinosus. M.H. Park, D.-Y. Suh and B.H. Han. (1996) Phytochemistry
43, 701-704.
25. Biological and pharmacological effects of pinusolide, a novel platelet activating
factor antagonist. H.O. Yang, Y.H. Kang, D.-Y. Suh, Y.C. Kim and B.H. Han.(1995)
Planta Med. 61, 519-522.
26. In vitro inhibition of cyclooxygenase by aspalatone. D.-Y. Suh and B.H. Han. (1995)
Yakhak Hoeji 39, 565-568.
27. Metabolic fate of the new antithrombotic agent aspalatone in rats. In vivo and in vitro
study. D.-Y. Suh, H.O. Yang, Y.C. Kim and B.H. Han. (1995) Arzneim.
Forsch./Drug Res. 45(II), 1071-1074.
28. Total synthesis of sanjoinine-G1. B.H. Han, Y.C. Kim, M.K. Park, J.H. Park, H.J.
Go, H.O. Yang, D.-Y. Suh and Y.H. Kang. Heterocycles (1995) 41, 1904-1914.
29. Isolation and characterization of platelet-activating factor receptor binding
antagonists from Biota orientalis. H.O. Yang, D.-Y. Suh and B.H. Han. (1995)
Planta Med. 61, 37-40.
30. Maltol, an antioxidant component of Korean red ginseng, shows little prooxident
activity. D.-Y. Suh, Y.N. Han and B.H. Han. (1994) Arch. Pharm. Res. 19, 112-115.
31. Synthesis and antiplatelet effects of the new antithrombotic agent Aspalatone with
low ulcerogenicity. B.H. Han, D.-Y. Suh, H.O. Yang, Y.-H. Kang and Y.C. Kim.
(1994) Arzneim. Forsch./Drug Res. 44(II), 1122-1126.
32. Reduced anti-inflammatory activity of acetylsalicylic acid maltol ester, aspalatone.
B.H. Han, D.-Y. Suh, H.O. Yang, S.J. Lee and H.P. Kim. (1994) Arch. Pharm. Res.
17, 166-169.
33. Chemical and biochemical studies on non-saponin constituents of Korean ginseng.
B.H. Han, M.H. Park, Y.N. Han and D.-Y. Suh. (1992) Korean J. Ginseng Sci. 16,
228-234.